CN105013013B - 一种皮肤溃疡修复基质的制备方法 - Google Patents
一种皮肤溃疡修复基质的制备方法 Download PDFInfo
- Publication number
- CN105013013B CN105013013B CN201510454579.3A CN201510454579A CN105013013B CN 105013013 B CN105013013 B CN 105013013B CN 201510454579 A CN201510454579 A CN 201510454579A CN 105013013 B CN105013013 B CN 105013013B
- Authority
- CN
- China
- Prior art keywords
- culture medium
- extracellular matrix
- cells
- matrix
- skin ulcer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010040943 Skin Ulcer Diseases 0.000 title claims abstract description 39
- 239000011159 matrix material Substances 0.000 title claims abstract description 39
- 231100000019 skin ulcer Toxicity 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 210000004027 cell Anatomy 0.000 claims abstract description 91
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims abstract description 78
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims abstract description 78
- 210000002744 extracellular matrix Anatomy 0.000 claims abstract description 78
- 238000000034 method Methods 0.000 claims abstract description 37
- 238000004108 freeze drying Methods 0.000 claims abstract description 27
- 230000001954 sterilising effect Effects 0.000 claims abstract description 20
- 210000000170 cell membrane Anatomy 0.000 claims abstract description 17
- 230000008439 repair process Effects 0.000 claims abstract description 17
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 10
- 239000000427 antigen Substances 0.000 claims abstract description 8
- 102000036639 antigens Human genes 0.000 claims abstract description 8
- 108091007433 antigens Proteins 0.000 claims abstract description 8
- 230000008719 thickening Effects 0.000 claims abstract description 6
- 239000002131 composite material Substances 0.000 claims abstract description 4
- 239000001963 growth medium Substances 0.000 claims description 81
- 241000283690 Bos taurus Species 0.000 claims description 52
- 210000003516 pericardium Anatomy 0.000 claims description 43
- 210000004379 membrane Anatomy 0.000 claims description 41
- 102000008186 Collagen Human genes 0.000 claims description 35
- 108010035532 Collagen Proteins 0.000 claims description 35
- 229920001436 collagen Polymers 0.000 claims description 34
- 210000003491 skin Anatomy 0.000 claims description 28
- 238000012258 culturing Methods 0.000 claims description 25
- 239000003513 alkali Substances 0.000 claims description 23
- 210000001519 tissue Anatomy 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 20
- 238000011081 inoculation Methods 0.000 claims description 18
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 16
- 210000000130 stem cell Anatomy 0.000 claims description 16
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 claims description 15
- 238000002791 soaking Methods 0.000 claims description 15
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 14
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 14
- 230000035876 healing Effects 0.000 claims description 13
- 238000000338 in vitro Methods 0.000 claims description 11
- 238000004806 packaging method and process Methods 0.000 claims description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 238000005406 washing Methods 0.000 claims description 10
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 9
- 229930024421 Adenine Natural products 0.000 claims description 9
- 229960000643 adenine Drugs 0.000 claims description 9
- 239000007640 basal medium Substances 0.000 claims description 9
- 239000002585 base Substances 0.000 claims description 9
- 230000001817 pituitary effect Effects 0.000 claims description 9
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 8
- 210000002950 fibroblast Anatomy 0.000 claims description 8
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 7
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 7
- 102000004877 Insulin Human genes 0.000 claims description 7
- 108090001061 Insulin Proteins 0.000 claims description 7
- 102000004338 Transferrin Human genes 0.000 claims description 7
- 108090000901 Transferrin Proteins 0.000 claims description 7
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 7
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 7
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 7
- 230000003203 everyday effect Effects 0.000 claims description 7
- 229960000890 hydrocortisone Drugs 0.000 claims description 7
- 229940125396 insulin Drugs 0.000 claims description 7
- 210000004303 peritoneum Anatomy 0.000 claims description 7
- 239000011781 sodium selenite Substances 0.000 claims description 7
- 235000015921 sodium selenite Nutrition 0.000 claims description 7
- 229960001471 sodium selenite Drugs 0.000 claims description 7
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 7
- 239000012581 transferrin Substances 0.000 claims description 7
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims description 6
- 101800003838 Epidermal growth factor Proteins 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 230000000735 allogeneic effect Effects 0.000 claims description 6
- 229940116977 epidermal growth factor Drugs 0.000 claims description 6
- 239000012894 fetal calf serum Substances 0.000 claims description 6
- 210000003954 umbilical cord Anatomy 0.000 claims description 6
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- 239000005708 Sodium hypochlorite Substances 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 244000309466 calf Species 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 5
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 210000004700 fetal blood Anatomy 0.000 claims description 4
- 230000002779 inactivation Effects 0.000 claims description 4
- 230000001678 irradiating effect Effects 0.000 claims description 4
- 239000012980 RPMI-1640 medium Substances 0.000 claims description 3
- 210000001691 amnion Anatomy 0.000 claims description 3
- 210000001185 bone marrow Anatomy 0.000 claims description 3
- 210000003074 dental pulp Anatomy 0.000 claims description 3
- 238000001976 enzyme digestion Methods 0.000 claims description 3
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 3
- 210000004185 liver Anatomy 0.000 claims description 3
- 239000007758 minimum essential medium Substances 0.000 claims description 3
- 210000002200 mouth mucosa Anatomy 0.000 claims description 3
- 210000001178 neural stem cell Anatomy 0.000 claims description 3
- 230000010355 oscillation Effects 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 238000004080 punching Methods 0.000 claims description 2
- 208000027418 Wounds and injury Diseases 0.000 abstract description 40
- 230000000694 effects Effects 0.000 abstract description 18
- 230000008569 process Effects 0.000 abstract description 11
- 208000032544 Cicatrix Diseases 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 230000037311 normal skin Effects 0.000 abstract description 5
- 231100000241 scar Toxicity 0.000 abstract description 5
- 230000037387 scars Effects 0.000 abstract description 5
- 238000003860 storage Methods 0.000 abstract description 5
- 230000002035 prolonged effect Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 238000013517 stratification Methods 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 46
- 206010052428 Wound Diseases 0.000 description 36
- 239000012528 membrane Substances 0.000 description 25
- 210000004207 dermis Anatomy 0.000 description 19
- 239000000463 material Substances 0.000 description 15
- 206010053615 Thermal burn Diseases 0.000 description 12
- 241000700159 Rattus Species 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- 239000003102 growth factor Substances 0.000 description 8
- 230000010261 cell growth Effects 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 230000007547 defect Effects 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 208000025865 Ulcer Diseases 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 230000029663 wound healing Effects 0.000 description 5
- 230000004663 cell proliferation Effects 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 208000008960 Diabetic foot Diseases 0.000 description 3
- 208000000558 Varicose Ulcer Diseases 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 230000001464 adherent effect Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000001878 scanning electron micrograph Methods 0.000 description 3
- 230000036573 scar formation Effects 0.000 description 3
- 230000007480 spreading Effects 0.000 description 3
- 238000003892 spreading Methods 0.000 description 3
- 230000037314 wound repair Effects 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000003637 basic solution Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 102000000503 Collagen Type II Human genes 0.000 description 1
- 108010041390 Collagen Type II Proteins 0.000 description 1
- 102000001187 Collagen Type III Human genes 0.000 description 1
- 108010069502 Collagen Type III Proteins 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000003790 Foot Ulcer Diseases 0.000 description 1
- 208000004221 Multiple Trauma Diseases 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000032594 Vascular Remodeling Diseases 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 210000002514 epidermal stem cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911211191.5A CN110975011B (zh) | 2015-07-29 | 2015-07-29 | 一种皮肤溃疡修复基质的制备方法 |
CN201510454579.3A CN105013013B (zh) | 2015-07-29 | 2015-07-29 | 一种皮肤溃疡修复基质的制备方法 |
CN201911211194.9A CN110923193A (zh) | 2015-07-29 | 2015-07-29 | 皮肤溃疡修复基质用培养基的配制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510454579.3A CN105013013B (zh) | 2015-07-29 | 2015-07-29 | 一种皮肤溃疡修复基质的制备方法 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911211191.5A Division CN110975011B (zh) | 2015-07-29 | 2015-07-29 | 一种皮肤溃疡修复基质的制备方法 |
CN201911211194.9A Division CN110923193A (zh) | 2015-07-29 | 2015-07-29 | 皮肤溃疡修复基质用培养基的配制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105013013A CN105013013A (zh) | 2015-11-04 |
CN105013013B true CN105013013B (zh) | 2020-01-21 |
Family
ID=54403545
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911211191.5A Expired - Fee Related CN110975011B (zh) | 2015-07-29 | 2015-07-29 | 一种皮肤溃疡修复基质的制备方法 |
CN201510454579.3A Expired - Fee Related CN105013013B (zh) | 2015-07-29 | 2015-07-29 | 一种皮肤溃疡修复基质的制备方法 |
CN201911211194.9A Withdrawn CN110923193A (zh) | 2015-07-29 | 2015-07-29 | 皮肤溃疡修复基质用培养基的配制方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911211191.5A Expired - Fee Related CN110975011B (zh) | 2015-07-29 | 2015-07-29 | 一种皮肤溃疡修复基质的制备方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911211194.9A Withdrawn CN110923193A (zh) | 2015-07-29 | 2015-07-29 | 皮肤溃疡修复基质用培养基的配制方法 |
Country Status (1)
Country | Link |
---|---|
CN (3) | CN110975011B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105497983A (zh) * | 2015-12-15 | 2016-04-20 | 天津市康婷生物工程有限公司 | 一种简单高效的干细胞贴片制备方法 |
CN105688287A (zh) * | 2016-01-26 | 2016-06-22 | 深圳爱生再生医学科技有限公司 | 用于治疗皮肤创伤的羊膜贴片及其制备方法 |
CN106039293A (zh) * | 2016-07-28 | 2016-10-26 | 广州赛莱拉干细胞科技股份有限公司 | 一种修复皮肤溃疡的组合物及其制备方法 |
CN107586757A (zh) * | 2017-11-01 | 2018-01-16 | 天津昂赛细胞基因工程有限公司 | 一种猪间充质干细胞培养液及其制备方法 |
CN109234230B (zh) * | 2018-09-30 | 2021-05-25 | 广州赛莱拉干细胞科技股份有限公司 | 一种皮肤间充质干细胞的原代分离方法 |
CN111084905A (zh) * | 2019-12-10 | 2020-05-01 | 肖雁冰 | 利用羊膜间充质干细胞制备人工羊膜的方法 |
CN111808808A (zh) * | 2020-08-04 | 2020-10-23 | 北京臻溪谷医学研究中心(有限合伙) | 一种间充质干细胞在脱细胞异体真皮支架上的培养方法及其应用 |
CN113057938A (zh) * | 2021-03-31 | 2021-07-02 | 长沙海润生物技术有限公司 | 一种支持电子束灭菌的次氯酸液体及其制备方法 |
CN114246975B (zh) * | 2021-12-28 | 2022-12-20 | 中国科学院烟台海岸带研究所 | 一种负载干细胞的鱼胶原蛋白创面修复海绵及其制备方法 |
CN114732959A (zh) * | 2022-04-20 | 2022-07-12 | 中国医学科学院整形外科医院 | 一种脱细胞瘢痕皮肤支架材料及其制备方法与应用 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003084410A1 (en) * | 2002-04-01 | 2003-10-16 | Board Of Regents, The University Of Texas System | Composite material for wound repair |
CN1493261A (zh) * | 2003-09-02 | 2004-05-05 | 中国人民解放军第四军医大学口腔医学 | 一种组织工程真皮及其制备方法 |
CN1528253A (zh) * | 2003-10-17 | 2004-09-15 | 上海第二医科大学附属第九人民医院 | 组织工程复合皮肤及其制备方法 |
CN101361990A (zh) * | 2008-09-03 | 2009-02-11 | 陕西瑞盛生物科技有限公司 | 一种双层人工皮肤及其制备方法 |
CN102462864A (zh) * | 2010-11-12 | 2012-05-23 | 中国辐射防护研究院 | 一种组织工程皮肤构建新方法 |
WO2012088396A2 (en) * | 2010-12-22 | 2012-06-28 | University Of Florida Research Foundation, Inc. | Multilayered implant materials derived from amniotic membrane, methods of making the multilayered implant materials, and method of using multilayered implant materials |
CN102614547A (zh) * | 2012-03-13 | 2012-08-01 | 中山大学中山眼科中心 | 一种快速构建复层细胞的方法 |
WO2013096214A1 (en) * | 2011-12-19 | 2013-06-27 | Allosource | Flowable matrix compositions and methods |
CN104013999A (zh) * | 2014-06-11 | 2014-09-03 | 朱家源 | 组织工程皮肤及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5993844A (en) * | 1997-05-08 | 1999-11-30 | Organogenesis, Inc. | Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix |
CN100462059C (zh) * | 2005-05-25 | 2009-02-18 | 中国人民解放军第四军医大学口腔医院 | 修复皮肤缺损的人工皮肤的制备方法 |
CA2667214C (en) * | 2006-10-23 | 2015-12-01 | Cook Biotech Incorporated | Processed ecm materials with enhanced component profiles |
CN100563728C (zh) * | 2007-10-19 | 2009-12-02 | 中国人民解放军第四军医大学 | 含有外周血干细胞的组织工程皮肤及其制备方法 |
EP2307071B1 (en) * | 2008-06-20 | 2015-08-12 | Cook Biotech Incorporated | Composite extracellular matrix materials and medical products formed therefrom |
CN101486995B (zh) * | 2009-02-24 | 2011-01-05 | 中国检验检疫科学研究院 | 用于组织工程皮肤运输的培养基及其配制方法 |
EP2236544A1 (en) * | 2009-03-24 | 2010-10-06 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Collagen Implant |
US9566369B2 (en) * | 2010-02-26 | 2017-02-14 | Decell Technologies Inc. | Methods for tissue decellularization |
CN104524634B (zh) * | 2014-12-17 | 2017-01-18 | 陕西佰傲再生医学有限公司 | 一种组织修复材料的制备方法 |
-
2015
- 2015-07-29 CN CN201911211191.5A patent/CN110975011B/zh not_active Expired - Fee Related
- 2015-07-29 CN CN201510454579.3A patent/CN105013013B/zh not_active Expired - Fee Related
- 2015-07-29 CN CN201911211194.9A patent/CN110923193A/zh not_active Withdrawn
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003084410A1 (en) * | 2002-04-01 | 2003-10-16 | Board Of Regents, The University Of Texas System | Composite material for wound repair |
CN1493261A (zh) * | 2003-09-02 | 2004-05-05 | 中国人民解放军第四军医大学口腔医学 | 一种组织工程真皮及其制备方法 |
CN1528253A (zh) * | 2003-10-17 | 2004-09-15 | 上海第二医科大学附属第九人民医院 | 组织工程复合皮肤及其制备方法 |
CN101361990A (zh) * | 2008-09-03 | 2009-02-11 | 陕西瑞盛生物科技有限公司 | 一种双层人工皮肤及其制备方法 |
CN102462864A (zh) * | 2010-11-12 | 2012-05-23 | 中国辐射防护研究院 | 一种组织工程皮肤构建新方法 |
WO2012088396A2 (en) * | 2010-12-22 | 2012-06-28 | University Of Florida Research Foundation, Inc. | Multilayered implant materials derived from amniotic membrane, methods of making the multilayered implant materials, and method of using multilayered implant materials |
WO2013096214A1 (en) * | 2011-12-19 | 2013-06-27 | Allosource | Flowable matrix compositions and methods |
CN102614547A (zh) * | 2012-03-13 | 2012-08-01 | 中山大学中山眼科中心 | 一种快速构建复层细胞的方法 |
CN104013999A (zh) * | 2014-06-11 | 2014-09-03 | 朱家源 | 组织工程皮肤及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110975011A (zh) | 2020-04-10 |
CN110923193A (zh) | 2020-03-27 |
CN110975011B (zh) | 2022-06-14 |
CN105013013A (zh) | 2015-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105013013B (zh) | 一种皮肤溃疡修复基质的制备方法 | |
CN101361989B (zh) | 双层膜状组织修补材料及其制备方法 | |
CN101361990B (zh) | 一种双层人工皮肤及其制备方法 | |
JP2820796B2 (ja) | 生物療法性細胞被覆微小球状体 | |
CN101757691B (zh) | 一种组织工程角膜的制备方法 | |
Fang et al. | Clinical application of cultured epithelial autografts on acellular dermal matrices in the treatment of extended burn injuries | |
CN106730034B (zh) | 基于切片式去细胞支架构建的人工神经移植物及制备方法 | |
JPH08243156A (ja) | 培養皮膚およびその製造法 | |
WO2008083223A1 (en) | Methods for culturing dermal cells for treatment of skin injuries such as burns | |
WO2004048557A1 (en) | Treatment of tissue with undifferentiated mesenchymal cells | |
CN104055795B (zh) | 一种可注射植入剂及其制备方法 | |
US10098986B1 (en) | Ready to use biodegradable and biocompatible artificial skin substitute and a method of preparation thereof | |
CN100368534C (zh) | 生物衍生羊膜、复合生物衍生羊膜及其制备方法 | |
WO2021012677A1 (zh) | 一种仿生的预脉管化材料及其制备方法和应用 | |
CN107254431B (zh) | 一种新型组织工程皮肤制备方法 | |
JPH0947503A (ja) | 培養皮膚用基材、培養皮膚およびその製造法 | |
CN1232233C (zh) | 一种组织工程真皮的制备方法 | |
CN102178981B (zh) | 一种软骨修复支架材料的制备方法 | |
EP3350312B1 (en) | A method of culturing cells | |
JP3686068B2 (ja) | 皮膚の分離無細胞化方法、無細胞化真皮マトリックス及びその製造方法並びに無細胞化真皮マトリックスを用いた複合培養皮膚 | |
JP4344112B2 (ja) | 生体組織様構造体、骨髄幹細胞の培養方法および培養用キット | |
US20210015973A1 (en) | Human nipple areolar complex extracellular matrix scaffold and methods relating thereto | |
CN1363398A (zh) | 以壳多糖或其衍生物为基质网架的复层人工皮肤 | |
US20210220518A1 (en) | Producing method of the collagen-laminin matrix for healing ulcers, burns and wounds of a human skin | |
CN109498841A (zh) | 一种生物型骨膜修复材料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Taiwan high tech park of Songshan Lake high tech Industrial Development Zone of Dongguan City, Guangdong province 523808 Taoyuan Road No. 1, Dongguan Taiwan Biological Technology Cooperation Center 1 Building 1 room 05 Applicant after: Dongguan Bo and Regenerative Medicine Co.,Ltd. Address before: 710024 Shaanxi city of Xi'an Province South Second Ring Road, Yanta District Qinglong District Albert City building 11003 room 03 No. 1 vision Applicant before: SHAANXI BOYU REGENERATIVE MEDICINE Co.,Ltd. |
|
COR | Change of bibliographic data | ||
CB02 | Change of applicant information |
Address after: Taiwan high tech park of Songshan Lake high tech Industrial Development Zone of Dongguan City, Guangdong province 523808 Taoyuan Road No. 1, Dongguan Taiwan Biological Technology Cooperation Center 1 Building 1 room 05 Applicant after: GUANGDONG BO YU REGENERATIVE MEDICINE CO.,LTD. Address before: Taiwan high tech park of Songshan Lake high tech Industrial Development Zone of Dongguan City, Guangdong province 523808 Taoyuan Road No. 1, Dongguan Taiwan Biological Technology Cooperation Center 1 Building 1 room 05 Applicant before: Dongguan Bo and Regenerative Medicine Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200121 |